Company intelligence / Profile preview

Carter-Wallace

New York, New York, USA

Ownership: Private
Employees: ~4170
Development stage: Other

Overview

Carter-Wallace was a diversified, public healthcare conglomerate, known for pioneering consumer products (Arrid, Trojan), OTC medications (Carter’s Little Liver Pills), and prescription drugs (Miltown, Felbatol, Astelin). Most pharma products were commercialized for years; Felbatol was withdrawn due to safety concerns.

Therapeutic areas: PsychiatryImmunologyNeurologyWomen's Health
Modalities: Small moleculeOTC/Consumer productsDeviceAssay
Industry: Pharma

Partnerships

Joint ventures/licensing with Cameo Inc. (Pearl Drops)Others (some Indian/Asian JVs mentioned with CMM, Beiersdorf, Leukoplast, Winthrop, Old Spice)

Beyond the preview

Go deeper on Carter-Wallace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carter-Wallace.

Explore the full profile